ASCO 2019 Patient groups untested in cancer immunotherapy trials found to also benefit

ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit

09:00 EDT 31 May 2019 | ecancermedicalscience

Immunotherapy is a revolutionary cancer treatment, but it was unknown if cancer patients with HIV or viral hepatitis could also reap the benefits of this therapy because they had been excluded from most clinical trials. In an "encouraging" study to be...

More From BioPortfolio on "ASCO 2019: Patient groups untested in cancer immunotherapy trials found to also benefit"